Pelvic Inflammatory Disease (Neisseria gonorrhoeae)
Overview
Plain-Language Overview
Pelvic Inflammatory Disease (PID) is an infection of the female reproductive organs, including the uterus, fallopian tubes, and ovaries. It is commonly caused by bacteria such as Neisseria gonorrhoeae, which can spread from the vagina or cervix upward into the pelvic cavity. This infection affects the reproductive system and can cause symptoms like pelvic pain, fever, and abnormal vaginal discharge. If untreated, PID can lead to serious health problems such as infertility, chronic pelvic pain, and ectopic pregnancy. Early recognition and diagnosis are important to prevent these complications.
Clinical Definition
Pelvic Inflammatory Disease (PID) is an acute or chronic infection and inflammation of the upper female genital tract, including the endometrium, fallopian tubes, and adjacent pelvic structures. It is most commonly caused by ascending infection with sexually transmitted pathogens, particularly Neisseria gonorrhoeae and Chlamydia trachomatis. The core pathology involves bacterial invasion leading to salpingitis, endometritis, and tubo-ovarian abscess formation. PID is clinically significant due to its potential to cause tubal scarring, infertility, chronic pelvic pain, and increased risk of ectopic pregnancy. Diagnosis is often based on clinical presentation combined with laboratory and imaging findings. Prompt treatment is essential to reduce long-term sequelae.
Inciting Event
Sexual transmission of Neisseria gonorrhoeae initiates cervical infection.
Disruption of cervical mucosa during menstruation or childbirth facilitates bacterial ascent.
Insertion of an intrauterine device (IUD) in the presence of cervical infection can trigger PID.
Concurrent infection with other sexually transmitted pathogens like Chlamydia trachomatis enhances susceptibility.
Latency Period
Symptoms typically develop within 1 to 2 weeks after initial infection.
Subclinical infections may have a prolonged asymptomatic period before symptom onset.
Delayed presentation is common due to mild or nonspecific early symptoms.
Diagnostic Delay
Symptoms often mimic other causes of lower abdominal pain, leading to misdiagnosis as urinary tract infection or appendicitis.
Lack of specific early symptoms causes patients to delay seeking care.
Failure to perform pelvic examination and appropriate STI testing contributes to missed diagnosis.
Physician under-recognition of PID in young sexually active women delays treatment.
Clinical Presentation
Signs & Symptoms
Lower abdominal pain is the most common presenting symptom.
Abnormal vaginal discharge often purulent and malodorous.
Fever and chills indicate systemic infection.
Dyspareunia and dysuria may be reported.
Irregular menstrual bleeding or intermenstrual spotting can occur.
History of Present Illness
Patients typically report gradual onset of lower abdominal or pelvic pain worsening over days.
Associated symptoms include fever, abnormal vaginal discharge, and dyspareunia.
History often reveals recent unprotected sexual intercourse or new sexual partner.
Some patients describe intermenstrual or postcoital bleeding.
Symptoms may progress to include nausea, vomiting, and malaise in severe cases.
Past Medical History
Previous episodes of pelvic inflammatory disease increase risk of recurrence.
History of sexually transmitted infections, especially Chlamydia trachomatis or Neisseria gonorrhoeae.
Use of intrauterine devices (IUDs), particularly if inserted during active infection.
Prior pelvic or abdominal surgeries may alter anatomy and predispose to infection.
Family History
No significant heritable patterns or familial syndromes are associated with PID.
Family history is generally not contributory to risk or presentation.
Physical Exam Findings
Cervical motion tenderness is a hallmark finding on pelvic exam in pelvic inflammatory disease.
Adnexal tenderness and uterine tenderness are commonly observed during bimanual examination.
Purulent cervical discharge may be present and suggests active infection.
Fever and tachycardia can be noted in more severe cases.
Lower abdominal tenderness without peritoneal signs is typical.
Diagnostic Workup
Diagnostic Criteria
Diagnosis of PID is primarily clinical, based on the presence of lower abdominal or pelvic pain, cervical motion tenderness, uterine tenderness, or adnexal tenderness on pelvic exam. Additional supportive findings include fever, elevated white blood cell count, and purulent cervical discharge. Confirmatory diagnosis may involve positive nucleic acid amplification tests (NAATs) for Neisseria gonorrhoeae or Chlamydia trachomatis from cervical or vaginal swabs. Imaging such as transvaginal ultrasound can identify tubo-ovarian abscesses or thickened fallopian tubes. Laparoscopy is the gold standard but is reserved for uncertain cases.
Pathophysiology
Key Mechanisms
Ascending infection from the cervix to the upper genital tract causes inflammation of the endometrium, fallopian tubes, and adjacent pelvic structures.
Neisseria gonorrhoeae adheres to and invades mucosal epithelial cells, triggering a robust neutrophilic inflammatory response.
Release of proinflammatory cytokines leads to tissue edema, necrosis, and formation of tubo-ovarian abscesses.
Damage to fallopian tube epithelium causes scarring and fibrosis, resulting in chronic pelvic pain and infertility.
Disruption of normal mucosal barriers facilitates polymicrobial infection, often involving anaerobes and other sexually transmitted pathogens.
| Involvement | Details |
|---|---|
| Organs | Uterus is affected by ascending infection causing endometritis and pelvic pain. |
Fallopian tubes are the primary site of damage in pelvic inflammatory disease, leading to scarring and infertility. | |
Ovaries can develop abscesses in complicated pelvic inflammatory disease. | |
| Tissues | Endometrium is commonly inflamed in pelvic inflammatory disease, leading to endometritis and contributing to infertility risk. |
Fallopian tube mucosa is a key site of infection and scarring, causing tubal factor infertility and ectopic pregnancy risk. | |
Ovarian tissue may be involved in severe cases with abscess formation. | |
| Cells | Neutrophils are the primary immune cells infiltrating infected pelvic tissues, mediating acute inflammation and bacterial clearance. |
Macrophages contribute to phagocytosis of bacteria and release of proinflammatory cytokines in pelvic inflammatory disease. | |
Epithelial cells of the endocervix and fallopian tubes are initial sites of infection and contribute to local immune responses. | |
| Chemical Mediators | Interleukin-1 (IL-1) promotes inflammation and fever in response to bacterial infection in pelvic tissues. |
Tumor necrosis factor-alpha (TNF-α) mediates local tissue inflammation and systemic symptoms in pelvic inflammatory disease. | |
Prostaglandins contribute to pelvic pain and uterine contractions during inflammation. |
Treatments
Pharmacological Treatments
Ceftriaxone
- Mechanism:
Binds to penicillin-binding proteins to inhibit bacterial cell wall synthesis, effective against Neisseria gonorrhoeae.
- Side effects:
Allergic reactions
Gastrointestinal upset
Injection site pain
- Clinical role:
First-line
Doxycycline
- Mechanism:
Inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, covering common co-infecting organisms like Chlamydia trachomatis.
- Side effects:
Photosensitivity
Gastrointestinal upset
Tooth discoloration in children
- Clinical role:
First-line
Metronidazole
- Mechanism:
Disrupts DNA synthesis in anaerobic bacteria and protozoa, used to treat anaerobic infections often present in pelvic inflammatory disease.
- Side effects:
Metallic taste
Disulfiram-like reaction with alcohol
Gastrointestinal upset
- Clinical role:
Adjunctive
Non-pharmacological Treatments
Hospitalization and intravenous antibiotics for severe or complicated cases such as tubo-ovarian abscess.
Surgical drainage of abscesses if medical therapy fails or abscess ruptures.
Abstinence from sexual activity until completion of treatment and resolution of symptoms to prevent reinfection.
Prevention
Pharmacological Prevention
Screening and treatment of asymptomatic Neisseria gonorrhoeae infections in sexually active women reduces PID incidence.
Empiric antibiotic therapy for sexual partners prevents reinfection.
Post-exposure prophylaxis is not routinely recommended but partner treatment is critical.
Non-pharmacological Prevention
Consistent condom use reduces transmission of Neisseria gonorrhoeae and other STIs.
Regular STI screening in high-risk populations enables early detection and treatment.
Limiting number of sexual partners decreases exposure risk.
Prompt treatment of cervicitis and urethritis prevents ascending infection.
Outcome & Complications
Complications
Tubo-ovarian abscess formation is a serious complication requiring drainage.
Peritonitis can develop from rupture of infected structures.
Sepsis may occur in severe disseminated infections.
Infertility results from tubal scarring and obstruction.
Ectopic pregnancy risk increases due to damaged fallopian tubes.
| Short-term Sequelae | Long-term Sequelae |
|---|---|
|
|
Differential Diagnoses
Pelvic Inflammatory Disease (Neisseria gonorrhoeae) versus Ectopic Pregnancy
Pelvic Inflammatory Disease (Neisseria gonorrhoeae) | Ectopic Pregnancy |
|---|---|
Recent unprotected sexual intercourse with multiple partners | History of prior tubal surgery or assisted reproductive techniques |
Elevated inflammatory markers (e.g., ESR, CRP) with positive cervical swabs for Neisseria gonorrhoeae | Disproportionately elevated serum beta-hCG without intrauterine pregnancy on ultrasound |
Thickened, fluid-filled fallopian tubes with free pelvic fluid and no gestational sac | Adnexal mass with no intrauterine gestational sac on transvaginal ultrasound |
Pelvic Inflammatory Disease (Neisseria gonorrhoeae) versus Appendicitis
Pelvic Inflammatory Disease (Neisseria gonorrhoeae) | Appendicitis |
|---|---|
Bilateral lower abdominal pain with cervical motion tenderness | Right lower quadrant abdominal pain localized to McBurney's point |
Fever with purulent vaginal discharge and adnexal tenderness | Fever often accompanied by nausea and vomiting without vaginal discharge |
Dilated, fluid-filled fallopian tubes and tubo-ovarian abscess on pelvic ultrasound | Enlarged, noncompressible appendix on abdominal ultrasound or CT |
Pelvic Inflammatory Disease (Neisseria gonorrhoeae) versus Endometriosis
Pelvic Inflammatory Disease (Neisseria gonorrhoeae) | Endometriosis |
|---|---|
Acute or subacute pelvic pain with fever and cervical motion tenderness | Chronic cyclic pelvic pain worsening with menstruation |
Elevated ESR/CRP and positive cervical swabs for Neisseria gonorrhoeae | Normal inflammatory markers and negative cervical cultures |
Hydrosalpinx or tubo-ovarian abscess with complex adnexal masses | Endometriomas appearing as cystic ovarian masses with ground-glass echogenicity |
Pelvic Inflammatory Disease (Neisseria gonorrhoeae) versus Urinary Tract Infection (UTI)
Pelvic Inflammatory Disease (Neisseria gonorrhoeae) | Urinary Tract Infection (UTI) |
|---|---|
Lower abdominal pain with adnexal tenderness and cervical motion tenderness | Dysuria, frequency, and suprapubic pain without adnexal tenderness |
Positive cervical swabs for Neisseria gonorrhoeae and elevated inflammatory markers | Positive urine nitrites and leukocyte esterase with bacteriuria |
Requires broad-spectrum antibiotics covering Neisseria gonorrhoeae and anaerobes | Rapid symptom resolution with oral antibiotics targeting common uropathogens |
Pelvic Inflammatory Disease (Neisseria gonorrhoeae) versus Tubo-ovarian Abscess (TOA) from Polymicrobial Infection
Pelvic Inflammatory Disease (Neisseria gonorrhoeae) | Tubo-ovarian Abscess (TOA) from Polymicrobial Infection |
|---|---|
Predominantly Neisseria gonorrhoeae infection with possible Chlamydia trachomatis coinfection | Polymicrobial infection including anaerobes and facultative bacteria |
Dilated fallopian tubes with less complex fluid collections | Complex multiloculated adnexal mass with thick walls and septations |
Responds to ceftriaxone plus doxycycline targeting Neisseria gonorrhoeae and Chlamydia | Requires broad-spectrum antibiotics including anaerobic coverage and possible drainage |